The repositioning of epigenetic probes/inhibitors identifies new anti-schistosomal lead compounds and chemotherapeutic targets

BACKGROUND: Praziquantel represents the frontline chemotherapy used to treat schistosomiasis, a neglected tropical disease (NTD) caused by infection with macro-parasitic blood fluke schistosomes. While this drug is safe, its inability to kill all schistosome lifecycle stages within the human host of...

Descripción completa

Detalles Bibliográficos
Autores principales: Whatley, Kezia C. L., Padalino, Gilda, Whiteland, Helen, Geyer, Kathrin K., Hulme, Benjamin J., Chalmers, Iain W., Forde-Thomas, Josephine, Ferla, Salvatore, Brancale, Andrea, Hoffmann, Karl F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881072/
https://www.ncbi.nlm.nih.gov/pubmed/31730617
http://dx.doi.org/10.1371/journal.pntd.0007693

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881072/
https://www.ncbi.nlm.nih.gov/pubmed/31730617
http://dx.doi.org/10.1371/journal.pntd.0007693

Ejemplares similares